NOMAD Power Solutions, Inc. (NMAD)
NMADNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$3.57
+0.0140 (+0.39%) today
Pre-market, Nov 9, 4:00 PM ET
- Market cap
- $57.48m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $2.36 to $8.38
- Average volume
- 209.1k
- Previous close
- $3.56
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$1.80m | -$1.82m | -$1.99m | -$2.35m |
| Net income | -$1.98m | -$2.54m | -$1.92m | -$2.19m |
News
8 latest- Lixte Completes Rebrand To NOMAD Power Solutions; Starts Trading As NMAD RTTNews · Jul 6, 2026
- Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch RTTNews · Jun 1, 2026
- After-Hours Biotech Gainers: Insider Buys, Trial Updates, And Strategic Deals Fuel Momentum RTTNews · Sep 11, 2025
- LIXTE Biotechnology Holdings, Inc. Regains Nasdaq Compliance Following Successful Capital RaiseQuiver Quantitative · Jul 16, 2025
- Lixte Biotechnology Holdings, Inc. Closes $1.5 Million Registered Direct Offering of Common StockQuiver Quantitative · Jul 8, 2025
- Lixte Biotechnology Holdings, Inc. Announces $5 Million Private Placement of Common Stock and Preferred SharesQuiver Quantitative · Jul 1, 2025
- LIXTE Biotechnology Updates Progress On LB-100 In Ovarian And Colorectal Cancer Trials RTTNews · Mar 27, 2025
- LIXTE Biotechnology Teams Up with Lurie Cancer Center to Initiate Clinical Trial of LB-100 and GSK’s Dostarlimab for Ovarian Clear Cell CancerQuiver Quantitative · Feb 25, 2025
The company
NOMAD Power Solutions, Inc. (Nasdaq: NMAD) is an energy infrastructure equipment and services company focused on the design, manufacture and deployment of transportable, utility-grade power and energy-storage systems. Through its NOMAD Transportable Power Systems subsidiary, the Company markets its systems under the Voyager platform. NOMAD's systems are engineered to provide rapidly deployable, relocatable power capacity for utility, commercial, industrial and other applications where grid capacity is unavailable, constrained or uneconomical.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- nomadpower.com/
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.